Bristol-Myers Boosted By Opdivo Sales, Growth Prospects

Firm discusses opportunities and challenges for immuno-oncology franchises during third quarter earnings call.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet